Myung In Pharm Co., Ltd. (317450)

Overview

Myung In Pharm Co., Ltd. is a renowned specialty pharmaceutical manufacturer located in South Korea, established in 1985. The company is distinguished for its dedicated focus on the development, manufacturing, and distribution of pharmaceuticals primarily aimed at addressing central nervous system (CNS) disorders alongside various other therapeutic areas. Over the years, Myung In Pharm has cultivated an extensive portfolio of products that address neurological disorders, cardiovascular ailments, diabetes, and a range of over-the-counter medications. With a notable emphasis on CNS therapies, the company has firmly positioned itself as a leading entity in the South Korean pharmaceutical market, actively collaborating with neurology departments in hospitals and maintaining a comprehensive nationwide sales network. Myung In Pharm operates cutting-edge manufacturing facilities that adhere to current good manufacturing practice (cGMP) standards, facilitating the production of both finished pharmaceuticals and active pharmaceutical ingredients (APIs) aimed at domestic and export markets. Furthermore, the company engages in strategic partnerships with esteemed international organizations and extends its business operations to export markets across Asia, Africa, and Latin America. Myung In Pharm is committed to advancing innovative treatments for conditions including Parkinson’s disease, schizophrenia, depression, and various cardiovascular diseases, while also contributing significantly to public health through the provision of high-quality generic and specialty medicines.

Products and Services

• CNS Treatments: Myung In Pharm specializes in developing pharmaceuticals targeted at central nervous system disorders. This includes innovative medications for conditions such as Parkinson's disease and schizophrenia, aimed at improving patient outcomes and quality of life.
• Cardiovascular Medications: The company offers a range of treatments designed to address cardiovascular conditions, assisting healthcare providers in managing heart health and related disorders.
• Diabetes Care: Myung In Pharm has developed medications and therapies for the management of diabetes, supporting patients through effective glycemic control and overall health maintenance.
• Over-the-Counter Medicines: The company produces a variety of OTC medications, which play a vital role in self-medication and provide accessible health solutions for common ailments.
• Active Pharmaceutical Ingredients (APIs): Myung In Pharm manufactures high-quality APIs that are crucial for drug formulation, catering to both domestic and international pharmaceutical markets.
• Contract Manufacturing: The company engages in contract manufacturing services for other pharmaceutical companies, leveraging its state-of-the-art facilities and regulatory compliance capabilities to meet diverse production needs.
• Strategic Partnerships: Building robust alliances with renowned international firms, Myung In Pharm enhances its product offerings and expands its global reach, facilitating entry into various markets across Asia, Africa, and Latin America.